Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-05-07

Clinical Trial Update: Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy [EARLY_Phase 1]

View source ↗

Summary

An early-phase safety study evaluating Lactobacillus fermented extract in cancer patients undergoing chemotherapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus Fermented Extract

Snippet

Sponsor: New Hope Medical Center | Conditions: Cancer | EARLY_Phase 1 | Status: WITHDRAWN